Caitlin John’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.54K Sell
12
-12
-50% -$3.56K ﹤0.01% 658
2025
Q4
$6.55K Sell
24
-5,303
-100% -$1.44M ﹤0.01% 599
2025
Q3
$1.44M Buy
5,327
+194
+4% +$52.8K 1% 30
2025
Q2
$1.41M Buy
+5,133
New +$1.4M 1.29% 24
2024
Q3
Sell
-70
Closed -$13.8K 880
2024
Q2
$13.8K Buy
70
+44
+169% +$9.09K 0.01% 405
2024
Q1
$5.58K Buy
26
+1
+4% +$210 ﹤0.01% 549
2023
Q4
$5.42K Buy
+25
New +$5.33K ﹤0.01% 535

Other funds holding CME

Caitlin John's CME Position: Q1 2026 in Review

Caitlin John reduced its CME Group (CME) stake by 50% in Q1 2026, selling an estimated $3.56K and leaving 12 shares worth $3.54K. The position accounts for ﹤0.01% of the portfolio, ranked #658.

Caitlin John first reported a position in CME in Q4 2023 and has held it in 7 quarters since. The position peaked at $1.44M in Q3 2025. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Caitlin John held 12 shares of CME Group worth $3.54K as of Q1 2026.
  • Caitlin John sold 12 CME Group shares in Q1 2026, an estimated $3.56K.
  • CME Group made up ﹤0.01% of Caitlin John's portfolio in Q1 2026, its #658 holding.
  • Caitlin John first reported a position in CME Group in Q4 2023 and has held it in 7 quarters since.
  • Caitlin John's CME Group position peaked at $1.44M in Q3 2025.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Caitlin John's 13F filing for Q1 2026, filed 13 May 2026.